R. Bressinck

Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

A. Menter, K. Papp, K. Gordon, 2006, International journal of dermatology.

Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.

E. Leibsohn, J. Herndon, J. Guin, 1988, Cutis.

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.

J. Weiss, R. Pariser, D. Pariser, 1995, Clinical therapeutics.

Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.

J. Koo, D. Piacquadio, L. Edwards, 1998, Clinical therapeutics.